Synchronous Motor with Hybrid Permanent Magnets on the Rotor

Powder metallurgy allows designers of electric motors to implement new magnetic circuit structures. A relatively new concept is the use of a magnet system consisting of various types of magnets on one rotor, for example sintered and bonded magnets. This concept has been applied to the design and manufacture of the four-pole rotor of a synchronous motor with 400 W power and a rotational speed of 1500 rpm. In this motor, the stator of an asynchronous motor type Sh 71-4B is applied. The application of the new construction of the rotor resulted in an increase in motor efficiency and power factor compared to an asynchronous motor with the same volume

Longitudinal assessment of S100B serum levels and clinical factors in youth patients with mood disorders

Abstract Mood disorders have been discussed as being in relation to glial pathology. S100B is a calcium-binding protein, and a marker of glial dysfunctions. Although alterations in the S100B expression may play a role in various central nervous system diseases, there are no studies on the potential role of S100B in mood disorders in adolescents and young adults . In a prospective two-year follow-up study, peripheral levels of S100B were investigated in 79 adolescent/young adult patients (aged 14–24 years), diagnosed with mood disorders and compared with 31 healthy control subjects. A comprehensive clinical interview was conducted which focused on clinical symptoms and diagnosis change. The diagnosis was established and verified at each control visit. Serum S100B concentrations were determined. We detected: lower S100B levels in medicated patients, compared with those who were drug-free, and healthy controls; higher S100B levels in a depressed group with a family history of affective disorder; correlations between age and medication status; sex-dependent differences in S100B levels; and lack a of correlation between the severity of depressive or hypo/manic symptoms. The results of our study indicate that S100B might be a trait-dependent rather than a state-dependent marker. Due to the lack of such studies in the youth population, further research should be performed. A relatively small sample size, a lack of exact age-matched control group, a high drop-out rate

Association study of a functional promoter polymorphism in the XBP1 gene and schizophrenia

Jönsson EG, Cichon S, Schumacher J, et al. Association study of a functional promoter polymorphism in the XBP1 gene and schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2006;141B(1):71-75.A functional promoter polymorphism (−116C/G) of the X-box binding protein 1 gene (XBP1) gene was reported to be associated with schizophrenia in Asian subjects. In a replication attempt, three European case-control samples comprising 2,182 German, Polish, and Swedish subjects, were genotyped for the XBP1 −116C/G polymorphism. Allele and genotype frequencies were compared between schizophrenic patients and control subjects. There were no significant case-control differences in any of the three samples, although in a meta-analysis with previous results comprising 3,612 subjects there was a borderline association between the −116G-containing genotypes and schizophrenia. We conclude that the functional XBP1 gene polymorphism is not of major importance to schizophrenia in the European populations investigated. It cannot be excluded, however, that the XBP1 polymorphism is involved in schizophrenia in other populations or adds minor susceptibility to the disorder

“Association study of a functional promoter polymorphism in theXBP1 gene and schizophrenia,” American Journal Of Medical Genetics Part B (Neuropsychiatric Genetics) 141B:71–75 (2006)

Jönsson EG, Cichon S, Schumacher J, et al. “Association study of a functional promoter polymorphism in theXBP1 gene and schizophrenia,” American Journal Of Medical Genetics Part B (Neuropsychiatric Genetics) 141B:71–75 (2006). American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2006;141B(4):430-432

The DTNBP1 (Dysbindin) Gene Contributes to Schizophrenia, Depending on Family History of the Disease

We have investigated the gene for dystrobrevin-binding protein 1 (DTNBP1), or dysbindin, which has been strongly suggested as a positional candidate gene for schizophrenia, in three samples of subjects with schizophrenia and unaffected control subjects of German (418 cases, 285 controls), Polish (294 cases, 113 controls), and Swedish (142 cases, 272 controls) descent. We analyzed five single-nucleotide polymorphisms (P1635, P1325, P1320, P1757, and P1578) and identified significant evidence of association in the Swedish sample but not in those from Germany or Poland. The results in the Swedish sample became even more significant after a separate analysis of those cases with a positive family history of schizophrenia, in whom the five-marker haplotype A-C-A-T-T showed a P value of .00009 (3.1% in controls, 17.8% in cases; OR 6.75; P=.00153 after Bonferroni correction). Our results suggest that genetic variation in the dysbindin gene is particularly involved in the development of schizophrenia in cases with a familial loading of the disease. This would also explain the difficulty of replicating this association in consecutively ascertained case-control samples, which usually comprise only a small proportion of subjects with a family history of disease